Vivosel produces cell and gene therapy products for clinical applications. We are in active collaboration with medical partners, clinics, and regulatory agencies to bring GMP-grade regenerative and immunomodulatory therapies to patients across Türkiye and beyond.
We deliver mesenchymal stem cell (MSC) therapies through licensed clinical collaboration centers throughout Türkiye.
Our treatments focus on:
Advanced cellular therapies to restore skin vitality and combat aging at the cellular level.
Regenerative treatments to stimulate hair follicles and promote natural hair growth and restoration.
Targeted therapies to support tissue regeneration and provide systemic anti-inflammatory benefits.
All therapies are based on Vivosel's GMP-compliant, umbilical cord–derived MSC platform.
We are experts in conducting clinical trials globally. Our clinical trials in Türkiye support the development and safety validation of next-generation cell therapies under local and international regulatory standards.
Vivosel offers access to therapeutic research opportunities. Eligibility for trials depends on medical criteria and trial phase.
To learn more, please fill out the form below or contact our clinical research team.
All trials conducted under strict Good Manufacturing Practice standards
Regulatory compliance across local and international frameworks
Active collaboration with leading medical centers and research institutions